Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Grover

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Clinical and Translational Gastroenterology|April 7, 2026
Immune Checkpoint Inhibitor Esophagitis: Clinical and Endoscopic Presentation, Treatment Outcomes, and ComplicationsMatthew J Townsend, Afeerah Mumtaz, Jordan S Sack, et al.
Immunotherapy|June 13, 2022
Multiple high-grade and rare immune-related adverse events in a colon cancer patient with genomic and cytokine profilingKevin Tyan, Osama Abu-Shawer, Joanna Baginska, et al.
Hepatology (Baltimore, Md.)|October 28, 2021
Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitisMichael Li, Danny Wong, Alexander S Vogel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor TherapyMatthew J Townsend, Mofei Liu, Anita Giobbie-Hurder, et al.
Familial Cancer|August 4, 2020
Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individualsChinedu Ukaegbu, Zohar Levi, Tara D Fehlmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 24, 2024
Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatitis in Hospitalized and Nonhospitalized PatientsMichael Li, Danny Wong, Jordan S Sack, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor-Induced HepatitisMichael Li, Danny Wong, Jordan S Sack, et al.
Journal of Clinical Gastroenterology|October 29, 2020
High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With CancerShilpa Grover, Walker D Redd, Joyce C Zhou, et al.
Cancer|November 15, 2022
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical courseAneesha Haryal, Matthew J Townsend, Vinitha Baskaran, et al.
The American Journal of Gastroenterology|April 1, 2010
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndromeElena M Stoffel, Rowena C Mercado, Wendy Kohlmann, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Clinical and Translational Gastroenterology|April 7, 2026
Immune Checkpoint Inhibitor Esophagitis: Clinical and Endoscopic Presentation, Treatment Outcomes, and ComplicationsMatthew J Townsend, Afeerah Mumtaz, Jordan S Sack, et al.
Immunotherapy|June 13, 2022
Multiple high-grade and rare immune-related adverse events in a colon cancer patient with genomic and cytokine profilingKevin Tyan, Osama Abu-Shawer, Joanna Baginska, et al.
Hepatology (Baltimore, Md.)|October 28, 2021
Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitisMichael Li, Danny Wong, Alexander S Vogel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Pancreatitis and Hyperlipasemia in the Setting of Immune Checkpoint Inhibitor TherapyMatthew J Townsend, Mofei Liu, Anita Giobbie-Hurder, et al.
Familial Cancer|August 4, 2020
Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individualsChinedu Ukaegbu, Zohar Levi, Tara D Fehlmann, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 24, 2024
Outcomes of High-Grade Immune Checkpoint Inhibitor Hepatitis in Hospitalized and Nonhospitalized PatientsMichael Li, Danny Wong, Jordan S Sack, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023
Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor-Induced HepatitisMichael Li, Danny Wong, Jordan S Sack, et al.
Journal of Clinical Gastroenterology|October 29, 2020
High Prevalence of Gastrointestinal Manifestations of COVID-19 Infection in Hospitalized Patients With CancerShilpa Grover, Walker D Redd, Joyce C Zhou, et al.
Cancer|November 15, 2022
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical courseAneesha Haryal, Matthew J Townsend, Vinitha Baskaran, et al.
The American Journal of Gastroenterology|April 1, 2010
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndromeElena M Stoffel, Rowena C Mercado, Wendy Kohlmann, et al.
Pageof 5